Addresses the issue of too much extrapolation from data on middle-aged white men in clinical research in the U.S. U.S. Food and Drug Administration's proposal or guidelines to guard against age bias; Absence of blacks in clinical trials; Claims that many medical treatments used on women are based on studies conducted on men.